Who owns AN2 THERAPEUTICS INC?
- Ticker: ANTX
- CUSIP Number: 037326105
Tip: Access positions for across all investors
Analyze quarterly positions in An2 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of An2 Therapeutics stock
Who bought or sold AN2 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Almitas Capital | 1.5M | $1.7M | 4% | Dec 2025 |
|
| Vanguard Group | 1.1M | $1.2M | 0% | Dec 2025 |
|
| Pfizer | 715k | $815k | 0% | Dec 2025 |
|
| Stonepine Capital Management | 628k | $716k | 11% | Dec 2025 |
|
| Peapod Lane Capital | 593k | $677k | 1% | Dec 2025 |
|
| Bank of Nova Scotia | 459k | $524k | 0% | Dec 2025 |
|
| Landscape Capital Management | 432k | $492k | -5% | Dec 2025 |
|
| Renaissance Technologies | 339k | $386k | -12% | Dec 2025 |
|
| BlackRock | 323k | $368k | 1% | Dec 2025 |
|
| Two Sigma Advisers | 268k | $340k | -1% | Sep 2025 |
|
| Geode Capital Management | 252k | $287k | 1% | Dec 2025 |
|
| Two Sigma Investments | 223k | $284k | -6% | Sep 2025 |
|
| Woodline Partners | 146k | $166k | 100% | Dec 2025 |
|
| State Street Corporation | 87k | $99k | 0% | Dec 2025 |
|
| Rangeley Capital | 65k | $74k | 0% | Dec 2025 |
|
| Squarepoint Ops | 62k | $70k | -4% | Dec 2025 |
|
| Bridgeway Capital Management | 60k | $76k | 0% | Sep 2025 |
|
| UBS Group | 57k | $65k | 0% | Dec 2025 |
|
| Northern Trust | 43k | $49k | 0% | Dec 2025 |
|
| Captrust Financial Advisors | 40k | $46k | 0% | Dec 2025 |
|
| Citadel Advisors | 23k | $29k | 84% | Sep 2025 |
|
| Private Advisor | 23k | $26k | 0% | Dec 2025 |
|
| Susquehanna International | 22k | $25k | 100% | Dec 2025 |
|
| Jane Street | 18k | $20k | 100% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 14k | $16k | 0% | Dec 2025 |
|
| Federated Investors | 12k | $13k | -3% | Dec 2025 |
|
| Valeo Financial Advisors | 10k | $12k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 10k | $12k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.0k | $2.3k | -4% | Dec 2025 |
|
| FMR | 1.0k | $1.3k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 303.00 | $344.995800 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 300.00 | $342.000000 | 0% | Dec 2025 |
|
| SBI Securities | 200.00 | $228.000000 | 0% | Dec 2025 |
|
Who sold out of An2 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Sep 2025 | 19k | $24k |
| ACT Advisors | Sep 2025 | 13k | $17k |
| Highline Wealth Partners | Sep 2025 | 5.0k | $6.4k |